Welcome to our dedicated page for KEYCORP /NEW/ SEC filings (Ticker: KEY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on KEYCORP /NEW/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into KEYCORP /NEW/'s regulatory disclosures and financial reporting.
KeyCorp director Elizabeth R. Gile reported a share conversion on Form 4. On 01/01/2026, 4,319 Deferred Shares were converted (transaction code M) into the same number of KeyCorp common shares. Following this transaction, she directly owned 45,201 common shares.
The report also shows continued ownership of 123,368 Deferred Shares, each of which is the economic equivalent of one common share. This Deferred Share balance includes approximately 4,244 dividend-equivalent Deferred Shares that accrued between June 2025 and December 2025.
KeyCorp director Alexander M. Cutler reported an update to his equity holdings in the company. On 12/31/2025, he acquired 1,090 deferred shares under KeyCorp’s Amended and Restated Directors' Deferred Share Sub-Plan, at a reference price of $20.64 per underlying common share. These deferred shares represent directors’ fees that have been converted into the economic equivalent of common shares.
Under the plan, payment of the deferred shares is postponed until the earlier of July 1, 2028 or the director’s death. After this transaction, Cutler beneficially owned 298,416 common shares directly and 56,370 deferred shares, which include approximately 548 dividend-equivalent deferred shares accrued in December 2025.
KeyCorp director Devina A. Rankin reported a fee deferral transaction involving deferred share units tied to KeyCorp common shares. On 12/31/2025, Rankin acquired 1,453 deferred shares under the Amended and Restated Directors' Deferred Share Sub-Plan to the KeyCorp Amended and Restated 2019 Equity Compensation Plan at a conversion price of $20.64 per underlying common share. These deferred shares are described as the economic equivalent of common shares, with payment deferred until the earlier of January 1, 2031, or the director’s death. Following this transaction, Rankin beneficially owned 79,346 derivative deferred shares, which includes approximately 773 dividend-equivalent deferred shares accrued in December 2025, and 13,430 common shares held directly.
KeyCorp director Robin N. Hayes reported equity award activity. On 01/01/2026, Hayes acquired 3,174 KeyCorp common shares through an option or deferred share conversion shown with transaction code "M," bringing direct beneficial ownership of common shares to 25,723.
In a related transaction, 1,453 deferred shares were credited as of 12/31/2025, each economically equivalent to one common share at a reference value of $20.64 per share. Following these transactions, Hayes beneficially owned 60,233 deferred shares, which include approximately 615 dividend-equivalent deferred shares accrued in December 2025. Under the Deferred Share Plan, payment of these deferred shares is postponed until the earlier of January 1, 2028, or the participant’s death.
KeyCorp filed a prospectus supplement registering 161,968,762 common shares, par value $1.00 per share, that were issued to The Bank of Nova Scotia under an Investment Agreement dated August 12, 2024. These shares were issued previously and are now covered by KeyCorp’s existing shelf Registration Statement on Form S-3 (No. 333-272573) through this supplement filed on December 23, 2025. The Investment Agreement required KeyCorp to file this prospectus supplement no later than December 27, 2025. In connection with the supplement, KeyCorp is also filing a legal opinion from Squire Patton Boggs (US) LLP and related consent as exhibits.
KeyCorp is registering the resale of 161,968,762 common shares previously issued to a single selling shareholder. These shares were issued under an Investment Agreement in two tranches, with the investor purchasing 47,829,359 shares on August 30, 2024 and 115,042,316 shares on December 27, 2024, each at $17.17 per share, for aggregate consideration of approximately $2.80 billion. The resale registration allows the selling shareholder, The Bank of Nova Scotia, to offer and sell some or all of these shares over time, but KeyCorp itself is not selling any shares and will not receive proceeds from these resale transactions. As of December 17, 2025, KeyCorp had 1,085,908,470 common shares outstanding, and its stock trades on the New York Stock Exchange under the symbol “KEY.”
KeyCorp disclosed that a reporting person who is both a director and a 10% owner disposed of 225,084 common shares on 12/16/2025 at a price of $20.22 per share. After this transaction, the reporting person beneficially owns 161,968,762 common shares directly.
The disposition is described as occurring under an Investment Agreement dated August 12, 2024 between the reporting person and KeyCorp, which provides for the reporting person to participate, in certain circumstances automatically, on a pro rata basis in any repurchase by KeyCorp of its common shares. For Section 16 purposes, the reporting person may be deemed a director-by-deputization because of its contractual right to nominate directors to KeyCorp’s board.
KeyCorp officer reports gifted share transfer and updated holdings
A senior KeyCorp officer, listed as Head of Institutional Bank, reported a Form 4 transaction involving KeyCorp common shares. On 12/10/2025, the reporting person transferred 12,500 KeyCorp common shares as a gift at a price of $0, which is classified as a disposition. Following this transaction, the officer directly owns 232,544 KeyCorp common shares. The filing also notes additional indirect holdings, including shares held through Paine Investments LP, the officer's spouse, a grantor retained annuity trust for the benefit of the officer and the officer's children, and a 401(k) plan.
KeyCorp insider reporting a director and 10% owner filed a Form 4 showing a sale of common shares. On 12/09/2025, the reporting person disposed of 100,316 KeyCorp common shares at $18.86 per share. After this transaction, the reporting person beneficially owned 162,193,846 common shares in direct form.
The disposition is described as occurring under an Investment Agreement dated August 12, 2024, which allows the reporting person to participate on a pro rata basis in certain repurchases of KeyCorp common shares by the company. For Section 16 purposes, the reporting person may be deemed a director-by-deputization due to its contractual right to nominate directors to KeyCorp’s board.
KeyCorp filed a current report to announce that it has posted a new investor presentation on its website. The presentation, dated December 9, 2025, is attached as Exhibit 99.1 and may be used in discussions with investors and analysts, including at the Goldman Sachs Financial Services Conference on that same date. The materials are available through the Investor Relations section of KeyCorp’s website.
The company states that the information in this investor presentation and in this report under Regulation FD is being furnished rather than filed, which means it is not subject to certain liability provisions of the federal securities laws and is not automatically incorporated into other securities filings.